Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 (R) Tetrahydroisoquinoline 1 Formic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104557911A details a chemo-enzymatic route for (R)-praziquantel. This method ensures high optical purity and significant cost reduction in anthelmintic drug manufacturing.
Patent CN105237532A reveals enzymatic route for L-praziquantel. Offers high optical purity and greener manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN104557911B reveals enzymatic deracemization for levo-praziquantel. Achieve high optical purity and cost reduction in pharmaceutical intermediates manufacturing with scalable green chemistry.